Inhibition of platelet GPIbα augments immunotherapy response in liver cancer via remodeling of the intrahepatic immune landscape

Shing Kam; Pierluigi Ramadori; S Zhang; T Bieler Tabea; D Camell; Roser Pinyol; E Ramon Gil; M D'Antonio; Donato Inverso; Wei Qiang Leow; Valerie Chew; D Heide; Sandra Prokosch; F Müller; Ulrike Rothermel; Nathanial R. Eddy; Ruslan D. Novosiadly; Jaclyn Neely; L Balcar; B Scheiner; Matthias Pinter; N Ben Khaled; F P Reiter; Andreas Weinmann; Catherine Leyh; C Roderburg; Friedrich Sinner; M Venerito; U Ehmer; Miguel Sogbe; Josep Maria Argemi; B Sangro; Wolfgang Ruf; David Štegner; J Leslie; D Mann; Josep M. Llovet; B Nieswandt; M Heikenwälder

doi:10.1055/s-0045-1814330

Article2019

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska, Donato Inverso, Elena Kotsiliti, Valentina Leone, Moritz Peiseler, Bas G. J. Surewaard, Dominik Rath, Adnan Ali, Monika Wolf, Hannah K. Drescher, Marc E. Healy, Daniel Dauch, Daniela C. Kroy, Oliver Krenkel, Marlene Kohlhepp, Thomas Engleitner, Alexander Olkus, Tjeerd Sijmonsma, Julia Volz, Carsten Deppermann, David Stegner, Patrick M. Helbling, César Nombela‐Arrieta, Anahita Rafiei, Martina Hinterleitner, Marcel Rall, Florian Baku, Oliver Borst, Caroline Wilson, Jack Leslie, Tracy O’Connor, Chris J. Weston, Abhishek Chauhan, David H. Adams, Lozan Sheriff, Ana Teijeiro, Marco Prinz, Ruzhica Bogeska, Natasha S. Anstee, Malte N. Bongers, Mike Notohamiprodjo, Tobias Geisler, Dominic J. Withers, Jerry Ware, Derek A. Mann, Hellmut G. Augustin, Alexandros Vegiopoulos, Michael D. Milsom, Adam J. Rose, Patricia F. Lalor, Josep M. Llovet, Roser Pinyol, Frank Tacke, Roland Rad, Matthias S. Matter, Nabil Djouder, Paul Kubes, Percy A. Knolle, Kristian Unger, Lars Zender, Bernhard Nieswandt, Meinrad Gawaz, Achim Weber, Mathias Heikenwälder

Nature Medicine

Corrigendum2022

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska, Donato Inverso, Elena Kotsiliti, Valentina Leone, Moritz Peiseler, Bas G. J. Surewaard, Dominik Rath, Adnan Ali, Monika Wolf, Hannah K. Drescher, Marc E. Healy, Daniel Dauch, Daniela C. Kroy, Oliver Krenkel, Marlene Kohlhepp, Thomas Engleitner, Alexander Olkus, Tjeerd Sijmonsma, Julia Volz, Carsten Deppermann, David Stegner,

Article2021

Inhibition of platelet GPIbα augments immunotherapy response in liver cancer via remodeling of the intrahepatic immune landscape

Discussion(0)

Related publications

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma

Landscape and functional impact of missense mutations of immune response genes in human cancer

Abstract 4834: 3D modeling of immune cell interactions in breast cancer and prediction of immunotherapy response